Supplemental material
Open access
1,137
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Real-world analysis of the economic and therapeutic burden in advanced breast cancer patients in Italy
Simona Palladinoa Novartis Farma S.p.A, Milan, ItalyView further author information
, Valentina Perroneb CliCon S.r.l. Società Benefit Health, Economics & Outcomes Research, Bologna, ItalyView further author information
, Elisa Giacominib CliCon S.r.l. Società Benefit Health, Economics & Outcomes Research, Bologna, ItalyView further author information
, Diego Sangiorgib CliCon S.r.l. Società Benefit Health, Economics & Outcomes Research, Bologna, ItalyView further author information
, Eleonora Premolia Novartis Farma S.p.A, Milan, ItalyView further author information
, Diletta Valsecchia Novartis Farma S.p.A, Milan, ItalyView further author information
, Luca Degli Espostib CliCon S.r.l. Società Benefit Health, Economics & Outcomes Research, Bologna, ItalyCorrespondence[email protected]
View further author information
& View further author information
Matteo Basilio Sutera Novartis Farma S.p.A, Milan, ItalyView further author information
show all
Pages 1041-1048
|
Received 07 Dec 2022, Accepted 29 Jun 2023, Published online: 17 Jul 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.